ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 550

Neutrophil Gelatinase Associated Lipocalin (NGAL/Lipocalin-2) Regulates the  Onset Of Serum Autoantibodies In Pristane Induced Lupus

Rahul Pawar1, Beatrice Goilav2, Yumin Xia1, Haoyang Zuang3, Leal Herlitz4, Westley H. Reeves5 and Chaim Putterman6, 1Albert Einstein College of Medicine, Bronx, NY, 2Division of Nephrology, Children's Hospital at Montefiore, Bronx, NY, 3University of Florida, Gainesville, FL, 4The Department of Pathology, Columbia University Medical Center, New York, NY, 5Medicine, University of Florida, Gainesville, FL, 6The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantibodies and neutrophil gelatinase associated lipocalin (NGAL), Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose:

NGAL (lipocalin-2), a member of the lipocalin superfamily, is expressed by a variety of cells including neutrophils, hepatocytes, alveolar epithelial cells and renal resident cells. NGAL is a sensitive marker for tissue injury, and is upregulated following ischemia, inflammatory conditions, metabolic diseases and neoplastic disorders. Furthermore, several studies have demonstrated the use of NGAL as a biomarker in lupus nephritis. Previously, NGAL was reported to be involved in innate immune responses during bacterial infection, and was found to worsen renal disease in nephrotoxic serum nephritis. However, the role of NGAL in adaptive immunity is still largely unknown. 

Methods:

To investigate a possible role for NGAL in adaptive immune responses in an experimental lupus model, we injected pristane (tetramethyl-pentadecane) (0.5 ml/mouse intraperitoneally) into wild type B6 (n=10) and NGAL-deficient (LCN2-/-) (n=10) mice. Wild type (WT) B6 and LCN-/- mice receiving PBS injections served as controls. Serum autoantibodies were analyzed by ELISA, Hep-2 immunostaining, and immunoprecipitation. Autoantibody producing cells were quantitated by ELISPOT. Expression of mRNA in spleen was performed by real-time qPCR.

Results:

Analyzing the levels of serum autoantibodies 4 months post pristane injection, we found that pristane challenged LCN2-/- mice had significant increases in IgG2b anti-single and anti-double stranded DNA as well as IgG anti-histone antibodies as compared to pristane injected B6 mice. Furthermore, elevated levels of serum anti-ribonucleoprotein antibodies were observed in pristane injected LCN2-/- mice by immunoprecipitation. Confirming these results, analysis of serum anti-nuclear antibodies (ANA) on Hep-2 cells revealed significantly increased homogenous and speckled staining in pristane challenged LCN2-/- mice as compared to WT B6 mice, while ELISPOT revealed increased numbers of autoantibody producing cells to DNA, histone and RNP in the spleen. Moreover, we found significant upregulation of interferon regulatory factor-5 (IRF5), IP-10, CXCL13, CXCR5, CXCR3, and activation induced cytidine deaminase (AID) in spleens of LCN2-/- mice compared to B6 mice post pristane challenge. Pristane promoted NGAL secretion by splenocytes in vitro, while pristane challenge in vivo induced significant upregulation of NGAL expression in the spleen and serum of B6 mice.

Conclusion:

NGAL/LCN2 deficiency accelerates the onset of anti-nuclear antibodies in pristane induced lupus, via increased levels of inflammatory mediators and autoantibody producing cells.


Disclosure:

R. Pawar,
None;

B. Goilav,
None;

Y. Xia,
None;

H. Zuang,
None;

L. Herlitz,
None;

W. H. Reeves,
None;

C. Putterman,

Biogen Idec,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophil-gelatinase-associated-lipocalin-ngallipocalin-2-regulates-the-onset-of-serum-autoantibodies-in-pristane-induced-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology